Erasca (NASDAQ: ERAS) director receives stock options for 29,888 shares

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Erasca, Inc. director Julie Hambleton reported receiving a stock option grant as part of her compensation. She was awarded options covering 29,888 shares of common stock at an exercise price of $16.01 per share. These options vest 100% on June 26, 2027, provided she continues serving the company through that date, and expire on June 26, 2036. Following this grant, she holds stock options for 29,888 shares directly. This is a compensation-related award rather than an open-market purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Hambleton Julie

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock option (right to buy)	29,888	$0.00	--

Holdings After Transaction: Stock option (right to buy) — 29,888 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Option grant size: 29,888 shares Exercise price: $16.01 per share Shares underlying options: 29,888 shares +3 more

6 metrics

Option grant size 29,888 shares Stock options on common stock granted to director

Exercise price $16.01 per share Exercise price for the stock options

Shares underlying options 29,888 shares Underlying common stock for this option grant

Vesting date June 26, 2027 100% of options vest on this date, subject to service

Expiration date June 26, 2036 Stock options expire if not exercised by this date

Options held after transaction 29,888 options Total derivative holdings reported following the grant

Key Terms

Stock option (right to buy), exercise price, expiration date, underlying security, +1 more

5 terms

Stock option (right to buy) financial

"security_title: Stock option (right to buy)"

exercise price financial

"conversion_or_exercise_price: 16.0100"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: 2036-06-26T00:00:00.000Z"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

underlying security financial

"underlying_security_title: Common Stock"

vest financial

"100% of the options to purchase shares vest on June 26, 2027"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/29/2026 - 07:03 PM Accepted by SEC EDGAR 06/29/2026 - 07:03 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hambleton Julie

(Last)

(First)

(Middle)

C/O ERASCA, INC.

3115 MERRYFIELD ROW, SUITE 300

(Street)

SAN DIEGO

CALIFORNIA

92121

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Erasca, Inc. [ ERAS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock option (right to buy)	$16.01	06/26/2026		A		29,888		06/26/2027⁽¹⁾	06/26/2036	Common Stock	29,888	$0	29,888	D

Explanation of Responses:

1. 100% of the options to purchase shares vest on June 26, 2027, subject to the Reporting Person's continuous service to the Issuer on such vesting date.

	/s/ Ebun S. Garner, as Attorney-in-Fact	06/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Erasca (ERAS) director Julie Hambleton report on this Form 4?

Julie Hambleton reported receiving a stock option grant for 29,888 shares of Erasca common stock. The options are a compensation-related award, not an open-market trade, and give her the right to buy shares at a fixed exercise price.

How many Erasca (ERAS) shares are covered by Julie Hambleton’s new stock options?

The grant covers options on 29,888 shares of Erasca common stock. These options represent potential future ownership if exercised and are all subject to a service-based vesting condition through June 26, 2027.

What is the exercise price of Julie Hambleton’s Erasca (ERAS) stock options?

The options have an exercise price of $16.01 per share. This means she can purchase Erasca common stock at $16.01 per share once the options vest, regardless of the future market price at exercise.

When do Julie Hambleton’s Erasca (ERAS) stock options vest and expire?

All of the options vest on June 26, 2027, assuming she continues to serve Erasca through that date. The options then remain exercisable until their expiration on June 26, 2036, after which any unexercised options lapse.

Is Julie Hambleton buying or selling Erasca (ERAS) stock in this Form 4?

She is not buying or selling stock on the market in this filing. Instead, she received a grant of stock options as compensation, giving a future right to purchase shares at a fixed exercise price if the options vest.

How many Erasca (ERAS) stock options does Julie Hambleton hold after this grant?

After this award, she holds stock options for 29,888 shares directly. This figure reflects the position reported in the filing and shows her derivative equity stake tied to the new grant.